{
  "openalex_id": "W2620254199",
  "doi": "https://doi.org/10.1136/bmj.j2216",
  "title": "Specific antidotes for bleeding associated with direct oral anticoagulants",
  "abstract": "#### What you need to know\n\nAn 83 year old woman is brought to the emergency department by her care giver who noticed her altered mental status following two episodes of passing black faeces. The woman has a history of ischaemic stroke associated with atrial fibrillation and hypertension and is on dabigatran for stroke prevention. She took her last dose a few hours ago. Computed tomography of the head shows no acute intracranial abnormalities. Abdominal and rectal exams are normal. Her blood pressure is 82/56 mm Hg. The multidisciplinary team in charge of her care arrives to talk with her and her family about antidotes for reversing her anticoagulation.\n\nDirect oral anticoagulants (DOACs) are a relatively new class of oral anticoagulants developed as alternatives to vitamin K antagonists such as warfarin, and are indicated in non-valvular atrial fibrillation and venous thromboembolism (Box 1).\n\n#### Box 1: Direct oral anticoagulants (DOACs)\n\n##### Commercially available DOACs include\n\nRandomised controlled trials and meta-analyses among patients with non-valvular atrial fibrillation or acute venous thromboembolism have shown DOACs to be at least as effective as vitamin K antagonists in preventing or treating thromboembolic events.3 4 …",
  "authors": [
    {
      "display_name": "Allison Burnett",
      "id": "A5082637516",
      "orcid": "https://orcid.org/0000-0002-8587-4975",
      "institutions": [
        {
          "id": "I169521973",
          "display_name": "University of New Mexico",
          "country_code": "US",
          "type": "funder"
        },
        {
          "id": "I1331310337",
          "display_name": "University of New Mexico Hospital",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Allison Burnett"
    },
    {
      "display_name": "Deborah Siegal",
      "id": "A5081541193",
      "orcid": "https://orcid.org/0000-0003-3806-3245",
      "institutions": [
        {
          "id": "I98251732",
          "display_name": "McMaster University",
          "country_code": "CA",
          "type": "funder"
        },
        {
          "id": "I2802834092",
          "display_name": "Population Health Research Institute",
          "country_code": "CA",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Deborah Siegal"
    },
    {
      "display_name": "Mark Crowther",
      "id": "A5079941141",
      "orcid": "https://orcid.org/0000-0003-4986-4873",
      "institutions": [
        {
          "id": "I98251732",
          "display_name": "McMaster University",
          "country_code": "CA",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Mark Crowther"
    }
  ],
  "publication_year": 2017,
  "publication_date": "2017-05-25",
  "type": "article",
  "cited_by_count": 19,
  "is_retracted": false,
  "is_paratext": false,
  "language": "en",
  "source": {
    "id": "S192814187",
    "display_name": "BMJ",
    "issn_l": "0959-8138",
    "issn": [
      "0959-8138"
    ],
    "type": "journal",
    "host_organization": "https://openalex.org/P4310319945"
  },
  "volume": null,
  "issue": null,
  "first_page": "j2216",
  "last_page": "j2216",
  "open_access": {
    "is_oa": false,
    "oa_status": "closed",
    "oa_url": null,
    "any_repository_has_fulltext": false
  },
  "concepts": [
    {
      "id": "C71924100",
      "display_name": "Medicine",
      "level": 0,
      "score": 0.91191643
    },
    {
      "id": "C2779161974",
      "display_name": "Atrial fibrillation",
      "level": 2,
      "score": 0.839896
    },
    {
      "id": "C2776301958",
      "display_name": "Warfarin",
      "level": 3,
      "score": 0.70491725
    },
    {
      "id": "C2780638905",
      "display_name": "Apixaban",
      "level": 5,
      "score": 0.631193
    },
    {
      "id": "C2780645631",
      "display_name": "Stroke (engine)",
      "level": 2,
      "score": 0.6044666
    },
    {
      "id": "C2778810321",
      "display_name": "Dabigatran",
      "level": 4,
      "score": 0.595028
    },
    {
      "id": "C2780724011",
      "display_name": "Emergency department",
      "level": 2,
      "score": 0.4203944
    },
    {
      "id": "C2778661090",
      "display_name": "Rivaroxaban",
      "level": 4,
      "score": 0.39503688
    },
    {
      "id": "C126322002",
      "display_name": "Internal medicine",
      "level": 1,
      "score": 0.39182335
    },
    {
      "id": "C42219234",
      "display_name": "Anesthesia",
      "level": 1,
      "score": 0.35520133
    },
    {
      "id": "C177713679",
      "display_name": "Intensive care medicine",
      "level": 1,
      "score": 0.34050322
    },
    {
      "id": "C164705383",
      "display_name": "Cardiology",
      "level": 1,
      "score": 0.32782066
    },
    {
      "id": "C78519656",
      "display_name": "Mechanical engineering",
      "level": 1,
      "score": 0.0
    },
    {
      "id": "C118552586",
      "display_name": "Psychiatry",
      "level": 1,
      "score": 0.0
    },
    {
      "id": "C127413603",
      "display_name": "Engineering",
      "level": 0,
      "score": 0.0
    }
  ],
  "topics": [
    {
      "id": "T10065",
      "display_name": "Atrial Fibrillation Management and Outcomes",
      "score": 0.9998
    },
    {
      "id": "T10285",
      "display_name": "Venous Thromboembolism Diagnosis and Management",
      "score": 0.9998
    },
    {
      "id": "T13878",
      "display_name": "Case Reports on Hematomas",
      "score": 0.9815
    }
  ],
  "created_date": null,
  "updated_date": null,
  "indexed_in": [],
  "landing_page_url": "https://doi.org/10.1136/bmj.j2216",
  "pdf_url": null,
  "retrieved_date": "2025-07-30T14:30:17.280524",
  "source_database": "OpenAlex"
}